Ascorbic Acid
Active ingredient · 3 therapeutic classes
Sold as Diatrol · Vitavera · Folartex · Davimet-M · Multitol-M
- Drug class
- Ascorbic Acid (Vitamin C), Plain
- Availability
- Prescription and OTC
- Routes
- Oral, Intravenous, Topical, Intramuscular
- Markets covered
- 3
- Products on record
- 68
- FDA reports (12 mo)
- 1,099
Overview
Plain-language summary, compiled from the cited regulatory records
Ascorbic Acid is a vitamin that is part of the Ascorbic Acid (Vitamin C), Plain drug class [1]. It is indicated for the dietary management of patients with nutritional deficiencies or those who require nutritional supplementation [1].
This ingredient is available under various brand names, including PNV-DHA, Immuno Fortifier, and Vitavera [1]. In the past 12 months, there have been 1099 adverse event reports associated with products containing Ascorbic Acid [2]. The most frequently reported adverse events include fatigue, off-label use, nausea, diarrhea, and headache [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 37 | May 19, 2026 |
| US United States | FDA | 24 | January 27, 2027 |
| CA Canada | Health Canada | 7 | April 29, 2026 |
GBUnited Kingdom· MHRA
37 products
Uses
The prevention and treatment of scurvy, or other conditions requiring vitamin C supplementation, where the deficiency is acute or oral administration is difficult.
How to take
USUnited States· FDA
24 products
Uses
INDICATIONS:
PNV-DHA is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.
How to take
CACanada· Health Canada
7 products
7 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Drug interactions
Known interactions involving Ascorbic Acid. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL351040006 · revised December 13, 2024
- [2]FDA DailyMed · 038fe2e7-dc16-48… · revised January 15, 2024 [PDF]
- [3]Health Canada (DPD) · 00780634 · revised March 22, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.